ischemic stroke - Nursing Case Study
Pathophysiology
• Primary mechanism: Atherosclerosis leads to plaque buildup in cerebral arteries, causing significant narrowing or blockage, which restricts blood flow and oxygen delivery to brain tissue, resulting in ischemia and subsequent neuronal injury or death.
• Secondary mechanism: Embolism, often originating from cardiac sources such as atrial fibrillation, travels to cerebral circulation, obstructing blood flow in smaller brain arteries, contributing to sudden ischemic events and further brain tissue damage.
• Key complication: Brain tissue ischemia prompts a cascade of inflammatory responses and excitotoxicity, exacerbating neuronal death and leading to potential long-term neurological deficits and disability.
Patient Profile
Demographics:
63-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin
• Allergies: No known drug allergies
Current Presentation:
• Chief complaint: Sudden onset weakness on the right side of the body
• Key symptoms: Slurred speech, facial droop on the right side, difficulty walking, headache
• Vital signs: Blood pressure 185/100 mmHg, Heart rate 92 bpm, Respiratory rate 22 breaths per minute, Temperature 98.7°F, Oxygen saturation 93% on room air
Section 1
New Diagnostic Results:
Following the initial presentation and admission to the emergency department, a CT scan of the patient's brain was promptly performed to confirm the diagnosis of an ischemic stroke and to rule out hemorrhagic stroke. The CT scan revealed a hypodense area in the distribution of the left middle cerebral artery, consistent with an acute ischemic event. Given the timeline of the stroke symptoms and the patient's presentation, the team considered the possibility of thrombolytic therapy. However, further examination of additional diagnostic tests, including a 12-lead ECG, revealed episodes of atrial fibrillation, which had not been previously diagnosed. This finding suggested that the stroke was likely embolic in nature, possibly originating from the heart.
In conjunction with the imaging results, laboratory tests were conducted to assess the patient's overall health and potential contributing factors. The lab results showed elevated low-density lipoprotein (LDL) levels at 160 mg/dL, above the target range for a patient with known hyperlipidemia, indicating suboptimal control of cholesterol levels. Additionally, the patient's blood glucose was measured at 210 mg/dL, reflecting poor glycemic control likely due to stress hyperglycemia from the acute event and possibly inadequate management of his Type 2 Diabetes Mellitus. The elevated blood pressure, noted on the initial assessment, remained a concern, as it increases the risk of further vascular complications.
These diagnostic findings required the healthcare team to refine the treatment plan, taking into account the atrial fibrillation's contribution to the stroke and the need for comprehensive management of the patient's chronic conditions. Decisions regarding anticoagulation therapy to prevent future embolic events were considered alongside optimizing the patient's antihypertensive and lipid-lowering treatments. This multifaceted approach aimed to stabilize the patient's acute condition while addressing the underlying risk factors to prevent further complications.
Section 2
Following the initiation of the revised treatment plan, the patient's status was closely monitored in the intensive care unit. Despite the administration of anticoagulation therapy with a heparin drip to address the atrial fibrillation and prevent further embolic events, the patient began to exhibit signs of neurological decline 48 hours post-admission. The clinical team noted a sudden increase in the patient's confusion and a right-sided weakness that had intensified compared to the initial presentation. Vital signs revealed a blood pressure of 185/100 mmHg, heart rate of 110 bpm, irregularly irregular, and oxygen saturation dropping to 90% on room air. There was also a noted decrease in verbal responsiveness and a Glasgow Coma Scale score of 10, indicating a significant change from the initial assessment.
In response to these developments, an urgent repeat CT scan of the brain was ordered to assess for any potential hemorrhagic transformation or extension of the ischemic area. The imaging results confirmed an increase in the size of the hypodense area in the left middle cerebral artery territory, suggesting an extension of the initial ischemic stroke. Additionally, the scan revealed subtle signs of hemorrhagic transformation, a known risk when anticoagulation therapy is initiated in the context of acute ischemic stroke. Laboratory tests showed a decrease in hemoglobin to 10 g/dL and a slight increase in INR, reinforcing the suspicion of a bleeding complication.
The healthcare team was faced with the challenge of balancing the management of the patient's atrial fibrillation and anticoagulation needs against the risk of further hemorrhagic transformation. This required careful adjustment of the therapeutic approach, including the potential reversal of anticoagulation and intensifying monitoring for any further neurological deterioration. The patient's complex presentation necessitated a multidisciplinary approach, engaging neurology, cardiology, and critical care specialists to optimize outcomes and mitigate the risks of further complications. The team's priority was to stabilize the patient's condition while addressing the underlying factors contributing to the current clinical picture.
Section 3
As the healthcare team worked to balance the management of atrial fibrillation and the risk of hemorrhagic transformation, they decided to cautiously reverse the anticoagulation therapy. A decision was made to administer protamine sulfate to counteract the effects of the heparin drip, given the evidence of hemorrhagic transformation on the CT scan. Concurrently, neurology recommended the initiation of hyperosmolar therapy with mannitol to manage cerebral edema, a strategy aimed at reducing intracranial pressure and potentially mitigating further neurological decline. The patient's vital signs continued to be closely monitored, with particular attention to blood pressure management, as hypertension posed a significant risk for exacerbating both ischemic and hemorrhagic components of the stroke.
Despite these interventions, the patient's neurological status showed only minimal improvement. The Glasgow Coma Scale score remained at 10, and the right-sided weakness persisted, indicating a need for further clinical evaluation. A repeat neurological examination revealed pupillary changes, with the left pupil becoming sluggishly reactive to light, suggesting increased intracranial pressure. The cardiology team reviewed the patient's cardiac status, noting that the irregularly irregular heart rate associated with atrial fibrillation remained a concern, and they considered the introduction of rate control medications with a plan to re-evaluate anticoagulation therapy once the risk of bleeding was adequately addressed.
The multidisciplinary team convened to discuss the next steps, acknowledging that the patient's condition was precarious but stable. They agreed on a plan to continue aggressive supportive care while maintaining vigilant monitoring for any further signs of deterioration. The possibility of surgical intervention to relieve intracranial pressure was discussed, though deemed premature at this stage. The team's focus remained on stabilizing the patient's cardiovascular and neurological status, with the hope of gradually reintroducing anticoagulation therapy once the risk of further hemorrhagic complications had subsided. This careful balancing act underscored the complexity of managing ischemic stroke with concurrent atrial fibrillation, highlighting the importance of ongoing assessment and adjustment of the treatment plan.
Section 4
As the team continued to manage the complex case, a new complication emerged. The patient's blood pressure, which had been closely monitored, began to show significant fluctuations, with readings as high as 190/110 mmHg. This hypertension was concerning, given the potential for exacerbating cerebral edema and increasing the risk of further hemorrhagic transformation. In response, the team initiated a more aggressive blood pressure management protocol, introducing intravenous labetalol to achieve better control. Despite these efforts, the patient exhibited increasing confusion and restlessness, suggesting a deterioration in neurological status.
A follow-up CT scan was ordered to assess any changes in the intracranial environment. The results revealed an increase in midline shift and worsening of the cerebral edema, although there was no significant expansion of the hemorrhagic area. This finding prompted the team to intensify hyperosmolar therapy, increasing the frequency of mannitol administration. Additionally, an arterial blood gas analysis indicated a slight respiratory alkalosis, possibly due to the patient's hyperventilation in response to increased intracranial pressure. These developments required the team to consider the delicate balance between managing the patient's cardiovascular stability and mitigating neurological decline.
The patient's renal function, which had been stable, now showed a slight elevation in creatinine levels, likely secondary to the increased mannitol use. This prompted the nephrology team to become involved, advising close monitoring of fluid balance and renal function tests to prevent further complications. While surgical intervention was still considered a last resort, the team prepared for the possibility by consulting neurosurgery for a potential decompressive craniectomy if the patient's condition continued to deteriorate. The multidisciplinary approach remained crucial, as each decision had to be weighed carefully to optimize outcomes while minimizing risks.
Section 5
As the team continued to monitor the patient closely, a new complication emerged that added to the complexity of the case. The patient's respiratory status began to decline, marked by an increase in respiratory rate to 28 breaths per minute and a decrease in oxygen saturation to 92% on room air. Upon auscultation, diminished breath sounds were noted bilaterally, and a follow-up chest X-ray revealed bilateral pulmonary infiltrates suggestive of aspiration pneumonia. This development was likely a consequence of the patient's altered mental status and impaired swallowing reflex, which increased the risk for aspiration.
In response to these findings, the team initiated broad-spectrum antibiotics to address the potential infection and adjusted the patient's position to optimize ventilation. Additionally, the decision was made to place the patient on supplemental oxygen to maintain adequate oxygenation. The introduction of a speech and language pathologist to assess swallowing function and implement strategies to reduce aspiration risk became a priority.
Clinically, the increased respiratory effort was concerning, as it could further exacerbate the patient's respiratory alkalosis. The team recognized the need to maintain a delicate balance between improving respiratory function and preventing further neurological compromise due to fluctuating intracranial pressure. As such, careful monitoring of arterial blood gases and electrolytes was deemed necessary to guide ongoing management. This new complication underscored the importance of a holistic approach, integrating respiratory support with neurological and renal considerations to stabilize the patient's condition and prevent further deterioration.